Kugelmeiers Ltd.

Kugelmeiers Ltd. is a Swiss health care startup founded in 2015 with a focus on "Enabling Unlimited Cell Therapies." The company envisions a future where medical care is driven by health rather than disease, offering safe stem cell treatments and regenerative therapies accessible to all. Kugelmeiers Ltd. prides itself on being ethical, responsible, and visionary, with an imminent undertaking in 2019 to modify islet transplantation for diabetes treatment. As a spin-off from the University of Zurich, the company brings together a team of medical, research, and transplant specialists, along with serial entrepreneurs, aiming to develop stem cell therapies for future medical applications. With a focus on putting "HUMAN FIRST," Kugelmeiers Ltd. exemplifies a promising investment opportunity in the field of regenerative medicine.